Antibiotic Resistance Pattern of Staphylococcus Aureus Isolated From Pediatrics With Ocular Infections: A 6-Year

Xiao-Yu Zheng1, Bonnie Nga Kwan Choy2, Ming-Ming Zhou3

  • 1Department of Ophthalmology, National Clinical Research Center for Child Health, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Frontiers in Pediatrics
|December 6, 2021
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) is prevalent in pediatric ocular infections in China, showing high multidrug resistance. Levofloxacin is effective against MRSA, while erythromycin resistance is common.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Microbiology

Background:

  • Staphylococcus aureus (S. aureus) is a significant cause of pediatric ocular infections.
  • Methicillin-resistant S. aureus (MRSA) poses a growing threat due to antibiotic resistance.

Purpose of the Study:

  • To determine the prevalence and antibiotic resistance patterns of S. aureus, particularly MRSA, in Chinese children with ocular infections.
  • To guide clinical treatment strategies for pediatric ocular infections.

Main Methods:

  • Retrospective review of S. aureus isolates from pediatric ocular infections (2015-2020).
  • Analysis of susceptibility testing results for S. aureus and MRSA strains.
  • Stratification of resistance patterns by patient age, ward, and specimen type.

Main Results:

  • 177 S. aureus ocular isolates were identified; 25.4% were MRSA.
  • MRSA showed high resistance to penicillin, erythromycin, and clindamycin, with a 71.1% multidrug resistance (MDR) rate.
  • MRSA remained highly sensitive to levofloxacin. MSSA resistance patterns varied across different patient and specimen groups.

Conclusions:

  • MRSA is a common and multidrug-resistant pathogen in pediatric ocular infections in Southeast China.
  • Levofloxacin is a potential effective treatment for ocular MRSA infections.
  • Antibiotic resistance patterns differ between MRSA and MSSA and require careful consideration for targeted therapy.